English | 简体中文 | 繁體中文 | 한국어
 All Press Releases

稳居中国宠物食品第一品牌:解码麦富迪护城河如何从"规模领先"升级为"系统性壁垒"
Jan 07, 2026 16:00 HKT
H3ロケット9号機による「みちびき7号機」の打上げ延期
Jan 07, 2026 12:00 HKT
HondaJetの機体性能を向上させる新しいパフォーマンスパッケージを発売
Jan 07, 2026 12:00 HKT
Hitachi Launches Expanded HMAX Solutions Accelerating Social Innovation Globally Across Industries
Jan 07, 2026 11:27 HKT
Fullerton Health Deepens Specialty Care Capabilities Through Acquisition of Singapore-Based Otolaryngology Practice, The ENT Clinic
Jan 07, 2026 10:30 HKT
天數智芯明日登陸港交所:軟硬件協同+全場景覆蓋 乘AI東風角逐全球算力高地
Jan 07, 2026 09:55 HKT
天数智芯明日登陆港交所:软硬件协同+全场景覆盖 乘AI东风角逐全球算力高地
Jan 07, 2026 09:55 HKT
Radisson Announces Additional High-Grade Drill Results and Further Extends New Mineralization Beneath the Historic O'Brien Gold Mine
Jan 06, 2026 20:00 HKT
Hong Kong Toys & Games Fair leads market innovation, debut 'Pop & Play' pavilion opens to industry and public
Jan 06, 2026 18:50 HKT
CTF Life Amplifies Ecosystem Synergy
Jan 06, 2026 15:35 HKT
周大福人壽深化集團協同效應  
Jan 06, 2026 15:35 HKT
Mitsubishi Motors to Celebrate "Delica Festival" with Custom Versions of Delica D:5 and Delica Mini at Tokyo Auto Salon 2026
Jan 06, 2026 15:25 HKT
Mitsubishi Motors Launches the Xforce in Taiwan
Jan 06, 2026 13:42 HKT
海外收入占比超九成 泳池清潔機器人龍頭望圓科技全球增長路徑逐漸清晰
Jan 06, 2026 13:12 HKT
海外收入占比超九成 泳池清洁机器人龙头望圆科技全球增长路径逐渐清晰
Jan 06, 2026 11:02 HKT
Black Spade Acquisition III Co宣佈為1.5億美元首次公開募股定價
Jan 06, 2026 09:54 HKT
Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Accepted in China

Jan 06, 2026 09:43 HKT
Black Spade Acquisition III Co宣布为1.5亿美元首次公开募股定价
Jan 06, 2026 09:37 HKT
iMe與Attractor:Web3大規模採用的突破性時刻
Jan 05, 2026 21:12 HKT
Notice on the Establishment of a Special Subsidiary
Jan 05, 2026 21:00 HKT
<< Previous Next >>
 Releases By Language
All
English
Indonesian
Japanese
Korean
Thai
Trad. Chinese
Simp. Chinese
Vietnamese
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: